Cargando…

O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses

BACKGROUND: Ovarian-Adnexal Reporting and Data System (O-RADS) for ultrasound is a lexicon and risk stratification system that includes all risk categories and relevant management recommendation. It has high sensitivity in diagnosing malignant adnexal tumors, but the specificity is lower. OBJECTIVE:...

Descripción completa

Detalles Bibliográficos
Autores principales: Shi, Yanyun, Li, Huan, Wu, Xiuhua, Li, Xiaoqin, Yang, Min
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2023
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399045/
https://www.ncbi.nlm.nih.gov/pubmed/37537697
http://dx.doi.org/10.1186/s13048-023-01243-w
_version_ 1785084186827161600
author Shi, Yanyun
Li, Huan
Wu, Xiuhua
Li, Xiaoqin
Yang, Min
author_facet Shi, Yanyun
Li, Huan
Wu, Xiuhua
Li, Xiaoqin
Yang, Min
author_sort Shi, Yanyun
collection PubMed
description BACKGROUND: Ovarian-Adnexal Reporting and Data System (O-RADS) for ultrasound is a lexicon and risk stratification system that includes all risk categories and relevant management recommendation. It has high sensitivity in diagnosing malignant adnexal tumors, but the specificity is lower. OBJECTIVE: To explore the value of O-RADS combined with contrast-enhanced ultrasound (CEUS) in risk stratification of adnexal masses. METHODS: A retrospective study was performed on 85 patients with 100 adnexal masses that preoperatively underwent conventional ultrasound as well as CEUS examination and obtained the postoperative pathological results. The masses were classified into O-RADS2, 3, 4, and 5 by conventional ultrasound. After contrast enhancement, the classification of O-RADS was adjusted according to CEUS imaging features. The O-RADS 2 and 3 lesions with suspected malignant features like irregular blood vessels or internal inhomogeneous hyperenhancement were upgraded to O-RADS 4, and the O-RADS 4 lesions with the above features were upgraded to O-RADS 5. The O-RADS 4 lesions with suspicious benign angiographic features like a regular vessel, interior hypoenhancement or non-enhancement were downgraded to O-RADS 3; the O-RADS 5 lesions with rim ring-enhancement and interior non-enhancement were downgraded to O-RADS 3. The sensitivity, specificity, accuracy, PPV, NPV, and AUC of the two methods were compared, taking pathological results as the gold standard. RESULTS: The sensitivity, specificity, accuracy, PPV, NPV, and AUC of O-RADS and O-RADS combined with CEUS in the diagnosis of malignant adnexal tumors were 96.6%, 66.2%, 75.0%, 53.8%, 97.9%, 0.910 and 96.6%, 91.5%, 93.0%, 82.4%, 98.5%, 0.962, respectively. The specificity, accuracy, PPV, and AUC of O-RADS combined with CEUS were considerably higher than those of O-RADS (P < 0.01). Furthermore, both methods had excellent sensitivity and NPV but there were no significant differences between them(P > 0.05). CONCLUSION: Combination of O-RADS and CEUS can significantly improve the specificity and PPV in diagnosing malignant adnexal tumors. It seems promising in the clinical application of risk stratification of adnexal masses.
format Online
Article
Text
id pubmed-10399045
institution National Center for Biotechnology Information
language English
publishDate 2023
publisher BioMed Central
record_format MEDLINE/PubMed
spelling pubmed-103990452023-08-04 O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses Shi, Yanyun Li, Huan Wu, Xiuhua Li, Xiaoqin Yang, Min J Ovarian Res Research BACKGROUND: Ovarian-Adnexal Reporting and Data System (O-RADS) for ultrasound is a lexicon and risk stratification system that includes all risk categories and relevant management recommendation. It has high sensitivity in diagnosing malignant adnexal tumors, but the specificity is lower. OBJECTIVE: To explore the value of O-RADS combined with contrast-enhanced ultrasound (CEUS) in risk stratification of adnexal masses. METHODS: A retrospective study was performed on 85 patients with 100 adnexal masses that preoperatively underwent conventional ultrasound as well as CEUS examination and obtained the postoperative pathological results. The masses were classified into O-RADS2, 3, 4, and 5 by conventional ultrasound. After contrast enhancement, the classification of O-RADS was adjusted according to CEUS imaging features. The O-RADS 2 and 3 lesions with suspected malignant features like irregular blood vessels or internal inhomogeneous hyperenhancement were upgraded to O-RADS 4, and the O-RADS 4 lesions with the above features were upgraded to O-RADS 5. The O-RADS 4 lesions with suspicious benign angiographic features like a regular vessel, interior hypoenhancement or non-enhancement were downgraded to O-RADS 3; the O-RADS 5 lesions with rim ring-enhancement and interior non-enhancement were downgraded to O-RADS 3. The sensitivity, specificity, accuracy, PPV, NPV, and AUC of the two methods were compared, taking pathological results as the gold standard. RESULTS: The sensitivity, specificity, accuracy, PPV, NPV, and AUC of O-RADS and O-RADS combined with CEUS in the diagnosis of malignant adnexal tumors were 96.6%, 66.2%, 75.0%, 53.8%, 97.9%, 0.910 and 96.6%, 91.5%, 93.0%, 82.4%, 98.5%, 0.962, respectively. The specificity, accuracy, PPV, and AUC of O-RADS combined with CEUS were considerably higher than those of O-RADS (P < 0.01). Furthermore, both methods had excellent sensitivity and NPV but there were no significant differences between them(P > 0.05). CONCLUSION: Combination of O-RADS and CEUS can significantly improve the specificity and PPV in diagnosing malignant adnexal tumors. It seems promising in the clinical application of risk stratification of adnexal masses. BioMed Central 2023-08-03 /pmc/articles/PMC10399045/ /pubmed/37537697 http://dx.doi.org/10.1186/s13048-023-01243-w Text en © The Author(s) 2023 https://creativecommons.org/licenses/by/4.0/Open Access This article is licensed under a Creative Commons Attribution 4.0 International License, which permits use, sharing, adaptation, distribution and reproduction in any medium or format, as long as you give appropriate credit to the original author(s) and the source, provide a link to the Creative Commons licence, and indicate if changes were made. The images or other third party material in this article are included in the article’s Creative Commons licence, unless indicated otherwise in a credit line to the material. If material is not included in the article’s Creative Commons licence and your intended use is not permitted by statutory regulation or exceeds the permitted use, you will need to obtain permission directly from the copyright holder. To view a copy of this licence, visit http://creativecommons.org/licenses/by/4.0/ (https://creativecommons.org/licenses/by/4.0/) . The Creative Commons Public Domain Dedication waiver (http://creativecommons.org/publicdomain/zero/1.0/ (https://creativecommons.org/publicdomain/zero/1.0/) ) applies to the data made available in this article, unless otherwise stated in a credit line to the data.
spellingShingle Research
Shi, Yanyun
Li, Huan
Wu, Xiuhua
Li, Xiaoqin
Yang, Min
O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title_full O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title_fullStr O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title_full_unstemmed O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title_short O-RADS combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
title_sort o-rads combined with contrast-enhanced ultrasound in risk stratification of adnexal masses
topic Research
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC10399045/
https://www.ncbi.nlm.nih.gov/pubmed/37537697
http://dx.doi.org/10.1186/s13048-023-01243-w
work_keys_str_mv AT shiyanyun oradscombinedwithcontrastenhancedultrasoundinriskstratificationofadnexalmasses
AT lihuan oradscombinedwithcontrastenhancedultrasoundinriskstratificationofadnexalmasses
AT wuxiuhua oradscombinedwithcontrastenhancedultrasoundinriskstratificationofadnexalmasses
AT lixiaoqin oradscombinedwithcontrastenhancedultrasoundinriskstratificationofadnexalmasses
AT yangmin oradscombinedwithcontrastenhancedultrasoundinriskstratificationofadnexalmasses